CABALETTA BIO, INC. Capital Expenditures
CABALETTA BIO, INC. (CABA) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- CABALETTA BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CABALETTA BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- CABALETTA BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $205.00K, a 45.48% decline year-over-year.
- CABALETTA BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $78.00K, a 69.17% decline year-over-year.
- CABALETTA BIO, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $1.23M, a 44.41% decline from fiscal 2024.
- CABALETTA BIO, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $2.21M, a 221.83% increase from fiscal 2023.
- CABALETTA BIO, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $687.00K, a 71.99% decline from fiscal 2022.
- CABALETTA BIO, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $2.45M, a 110.38% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $205.00K derived: sum of 3 quarters · filed 2026-08-13 | $283.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $205.00K derived: sum of 2 quarters · filed 2026-05-14 | $283.00K derived: sum of 3 quarters · filed 2026-05-14 | $444.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $283.00K derived: sum of 2 quarters · filed 2026-03-23 | $444.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.23M 10-K · filed 2026-03-23 |
| 2025-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $239.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.02M 10-Q · filed 2025-11-10 | $1.40M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $946.00K 10-Q · filed 2026-08-13 | $1.32M derived: sum of 3 quarters · filed 2026-08-13 | $1.57M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $785.00K 10-Q · filed 2026-05-14 | $1.16M derived: sum of 2 quarters · filed 2026-05-14 | $1.41M derived: sum of 3 quarters · filed 2026-05-14 | $2.18M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $629.00K derived: sum of 2 quarters · filed 2026-03-23 | $1.40M derived: sum of 3 quarters · filed 2026-03-23 | $2.21M 10-K · filed 2026-03-23 |
| 2024-09-30 | $253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.02M derived: sum of 2 quarters · filed 2025-11-10 | $1.83M 10-Q · filed 2025-11-10 | $2.02M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $770.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.58M 10-Q · filed 2025-08-07 | $1.77M derived: sum of 3 quarters · filed 2025-08-07 | $1.83M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $812.00K 10-Q · filed 2025-05-15 | $997.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.06M derived: sum of 3 quarters · filed 2025-05-15 | $1.12M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $250.00K derived: sum of 2 quarters · filed 2025-03-31 | $307.00K derived: sum of 3 quarters · filed 2025-03-31 | $687.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $122.00K derived: sum of 2 quarters · filed 2024-11-14 | $502.00K 10-Q · filed 2024-11-14 | $818.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $437.00K 10-Q · filed 2024-08-08 | $753.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.84M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $380.00K 10-Q · filed 2024-05-15 | $696.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.79M derived: sum of 3 quarters · filed 2024-05-15 | $2.69M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.41M derived: sum of 2 quarters · filed 2024-03-21 | $2.31M derived: sum of 3 quarters · filed 2024-03-21 | $2.45M 10-K · filed 2024-03-21 |
| 2022-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.99M derived: sum of 2 quarters · filed 2023-11-09 | $2.14M 10-Q · filed 2023-11-09 | $2.29M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $898.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.04M 10-Q · filed 2023-08-10 | $1.20M derived: sum of 3 quarters · filed 2023-08-10 | $1.73M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $147.00K 10-Q · filed 2023-05-11 | $298.00K derived: sum of 2 quarters · filed 2023-05-11 | $828.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.22M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $681.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.07M derived: sum of 3 quarters · filed 2023-03-16 | $1.17M 10-K · filed 2023-03-16 |
| 2021-09-30 | $530.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $918.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.01M 10-Q · filed 2022-11-10 | $1.24M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $388.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $485.00K 10-Q · filed 2022-08-11 | $712.00K derived: sum of 3 quarters · filed 2022-08-11 | $874.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $97.00K 10-Q · filed 2022-05-12 | $324.00K derived: sum of 2 quarters · filed 2022-05-12 | $486.00K derived: sum of 3 quarters · filed 2022-05-12 | $506.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $389.00K derived: sum of 2 quarters · filed 2022-03-17 | $409.00K derived: sum of 3 quarters · filed 2022-03-17 | $635.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $182.00K derived: sum of 2 quarters · filed 2021-11-01 | $408.00K 10-Q · filed 2021-11-01 | $681.00K derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $246.00K 10-Q · filed 2021-08-05 | $519.00K derived: sum of 3 quarters · filed 2021-08-05 | $559.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $226.00K 10-Q · filed 2021-05-03 | $499.00K derived: sum of 2 quarters · filed 2021-05-03 | $539.00K derived: sum of 3 quarters · filed 2021-05-03 | $739.00K derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $313.00K derived: sum of 2 quarters · filed 2021-03-16 | $513.00K derived: sum of 3 quarters · filed 2021-03-16 | $693.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $240.00K derived: sum of 2 quarters · filed 2020-11-10 | $420.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $380.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $180.00K 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |